Arcellx Inc (ACLX) stock forecast · rev $107.9M
Arcellx Inc (ACLX) is a biotechnology company listed on NASDAQ.
This ACLX forecast page states what the cached financials imply — not a price target and not a guarantee. Arcellx Inc outlooks on Lician start from reported revenue and the latest filing, then you decide.
Latest reported ACLX revenue for 2024-12-31 was $107.9M. Net income was -$107.3M. Revenue was down 2.2% from 2023-12-31 to 2024-12-31. ACLX currently screens at market cap $6.73B.
The near-term path: Revenue was down 2.2% from 2023-12-31 to 2024-12-31. A forecast that ignores that change is just a story.
ACLX currently screens at market cap $6.73B. Stretching today's multiple into 2026 without a filing reason is how thin forecast pages get ignored.
When the next ACLX 10-Q or 8-K lands, this outlook should move. Until then the SEC page is the source.
Not a prediction market. For the live quote and the full model, use the ACLX stock page.
Not investment advice.